🌼 Dandelion root wipes out 95% of colon cancer cells in lab tests 🧬 Could a common weed be a powerful cancer fighter? A groundbreaking study by the University of Windsor revealed that dandelion root extract (DRE) eliminated over 95% of colorectal cancer cells within 48 hours in laboratory conditions. Published in Oncotarget, the study found that DRE activates multiple cancer cell death pathways, indicating a complex and potent anticancer effect. Lead researcher Dr. Siyaram Pandey highlighted its rare ability to kill cancer cells without harming healthy ones—something conventional chemotherapy often cannot do. Why this matters: Low toxicity and naturally derived Targets only cancer cells Sparks new interest in plant-based cancer therapies Important caveat: These findings are from lab tests, not human clinical trials. “Most cells are dead within 48 hours,” said Pandey, “but that doesn’t mean patients will be cured in 48 hours.” Still, this research shines a light on the powerful potential of natural remedies and the urgent need for further clinical trials. #DandelionRoot #ColonCancer #CancerResearch #NaturalTherapy #ScienceNews #PlantPower #Oncotarget #UniversityOfWindsor #SiyaramPandey #MedicalBreakthrough #AlternativeMedicine #HopeThroughScience #NaturalCures #HealthInnovation

A Groundbreaking Moment in Cancer Research: World’s First Lung Cancer mRNA Vaccine Enters Human Trials 🧬💉 In a historic leap for oncology, scientists have officially launched the world’s first clinical trial of an mRNA vaccine for lung cancer—a potential game-changer in the fight against one of the deadliest cancers worldwide. Developed by BioNTech, the biotech firm behind one of the pioneering COVID-19 vaccines, the new vaccine—BNT116—is specifically designed to combat non-small cell lung cancer (NSCLC), which accounts for about 85% of all lung cancer cases. Unlike traditional treatments, BNT116 works by teaching the immune system to recognize and attack cancer cells, and to help prevent the cancer from coming back. If successful, it could redefine how we treat—and possibly even prevent—advanced lung cancer. The Phase 1 clinical trial is currently underway at 34 sites across seven countries, including the UK, United States, and Germany, marking a major milestone in personalized cancer immunotherapy. 🔬 Source: BioNTech via BioNTech Official Press Release #LungCancerVaccine #BioNTech #mRNAtechnology #CancerResearch #NSCLC #CancerTreatment #MedicalBreakthrough #Immunotherapy #BNT116 #LungCancerAwareness #ScienceNews #ClinicalTrials